Literature DB >> 30098983

Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size.

Kunisi S Venkatasubban1, Joseph L Johnson2, Jamie L Thomas2, Abdul Fauq2, Bernadette Cusack2, Terrone L Rosenberry3.   

Abstract

Carbamates are esters of substituted carbamic acids that react with acetylcholinesterase (AChE) by initially transferring the carbamoyl group to a serine residue in the enzyme active site accompanied by loss of the carbamate leaving group followed by hydrolysis of the carbamoyl enzyme. This hydrolysis, or decarbamoylation, is relatively slow, and half-lives of carbamoylated AChEs range from 4 min to more than 30 days. Therefore, carbamates are effective AChE inhibitors that have been developed as insecticides and as therapeutic agents. We show here, in contrast to a previous report, that decarbamoylation rate constants are independent of the leaving group for a series of carbamates with the same carbamoyl group. When the alkyl substituents on the carbamoyl group increased in size from N-monomethyl- to N,N-dimethyl-, N-ethyl-N-methyl-, or N,N-diethyl-, the decarbamoylation rate constants decreased by 4-, 70-, and 800-fold, respectively. We suggest that this relationship arises as a result of active site distortion, particularly in the acyl pocket of the active site. Furthermore, solvent deuterium oxide isotope effects for decarbamoylation decreased from 2.8 for N-monomethylcarbamoyl AChE to 1.1 for N,N-diethylcarbamoyl AChE, indicating a shift in the rate-limiting step from general acid-base catalysis to a likely conformational change in the distorted active site.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer's disease; Decarbamoylation

Mesh:

Substances:

Year:  2018        PMID: 30098983      PMCID: PMC6204216          DOI: 10.1016/j.abb.2018.08.006

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  32 in total

1.  Carbamylation of acetvlcholinesterase.

Authors:  I B WILSON; M A HATCH; S GINSBURG
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

2.  Interactions between the peripheral site and the acylation site in acetylcholinesterase.

Authors:  Terrone L Rosenberry; Joseph L Johnson; Bernadette Cusack; Jamie L Thomas; Sujata Emani; Kunisi S Venkatasubban
Journal:  Chem Biol Interact       Date:  2005-10-27       Impact factor: 5.192

3.  The half-life of acetylcholinesterase in mature rat brain.

Authors:  R J Wenthold; H R Mahler; W J Moore
Journal:  J Neurochem       Date:  1974-06       Impact factor: 5.372

4.  Studies of catalysis by acetylcholinesterase. Synergistic effects of inhibitors during the hydrolysis of acetic acid esters.

Authors:  T L Rosenberry; S A Bernhard
Journal:  Biochemistry       Date:  1972-11-07       Impact factor: 3.162

5.  Organophosphorylation of acetylcholinesterase in the presence of peripheral site ligands. Distinct effects of propidium and fasciculin.

Authors:  W D Mallender; T Szegletes; T L Rosenberry
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Crystal structures of acetylcholinesterase in complex with organophosphorus compounds suggest that the acyl pocket modulates the aging reaction by precluding the formation of the trigonal bipyramidal transition state.

Authors:  Andreas Hörnberg; Anna-Karin Tunemalm; Fredrik Ekström
Journal:  Biochemistry       Date:  2007-04-03       Impact factor: 3.162

7.  "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase.

Authors:  C Bartolucci; E Perola; L Cellai; M Brufani; D Lamba
Journal:  Biochemistry       Date:  1999-05-04       Impact factor: 3.162

Review 8.  Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.

Authors:  Andrey Kovalevsky; Donald K Blumenthal; Xiaolin Cheng; Palmer Taylor; Zoran Radić
Journal:  Ann N Y Acad Sci       Date:  2016-07-02       Impact factor: 5.691

9.  Quantitative simulation of endplate currents at neuromuscular junctions based on the reaction of acetylcholine with acetylcholine receptor and acetylcholinesterase.

Authors:  T L Rosenberry
Journal:  Biophys J       Date:  1979-05       Impact factor: 4.033

10.  A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia.

Authors:  Martin R Farlow; George T Grossberg; Carl H Sadowsky; Xiangyi Meng; Monique Somogyi
Journal:  CNS Neurosci Ther       Date:  2013-08-07       Impact factor: 5.243

View more
  2 in total

Review 1.  Rate-limiting step in the decarbamoylation of acetylcholinesterases with large carbamoyl groups.

Authors:  Terrone L Rosenberry; Jonah Cheung
Journal:  Chem Biol Interact       Date:  2019-06-06       Impact factor: 5.192

2.  Solvent Deuterium Oxide Isotope Effects on the Reactions of Organophosphorylated Acetylcholinesterase.

Authors:  Terrone L Rosenberry
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.